Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study

MLA

De Castro F., et al. Antitumor Effects Induced by the Promising Drug [Pt(O,O′-Acac)(γ-Acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): A 1H NMR Metabolomic Study. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4034..d998dee35c3d7fbb08b59154a5641137&authtype=sso&custid=ns315887.

APA

De Castro F., Benedetti M., Antonaci G., Del Coco L., De Pascali S. A., Muscella A., Marsigliante S., & Fanizzi F. P. (2018). Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study.

Chicago

De Castro F., Benedetti M., Antonaci G., Del Coco L., De Pascali S. A., Muscella A., Marsigliante S., and Fanizzi F. P. 2018. “Antitumor Effects Induced by the Promising Drug [Pt(O,O′-Acac)(γ-Acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): A 1H NMR Metabolomic Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4034..d998dee35c3d7fbb08b59154a5641137&authtype=sso&custid=ns315887.